Get started
RECURSION PHARMACEUTICALS, INCRECURSION PHARMACEUTICALS, INCRECURSION PHARMACEUTICALS, INC

RECURSION PHARMACEUTICALS, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

RXRX chart


Full chart

RXRX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪39.55 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−36.41 MXN
Net income (FY)
‪−9.67 B‬ MXN
Revenue (FY)
‪1.23 B‬ MXN
Shares float
‪310.78 M‬
Beta (1Y)
3.58

About Recursion Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Chistopher C. Gibson
Website
recursion.com
Headquarters
Salt Lake City
Founded
2013
FIGI
BBG01S8283M5
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Check out other big names from the same industry as RXRX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RXRX news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of RXRX is 93.50 MXN — it has decreased by −43.50% in the past 24 hours. Watch RECURSION PHARMACEUTICALS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange RECURSION PHARMACEUTICALS, INC stocks are traded under the ticker RXRX.
RXRX stock has fallen by −45.12% compared to the previous week, the month change is a −45.12% fall, over the last year RECURSION PHARMACEUTICALS, INC has showed a −49.23% decrease.
We've gathered analysts' opinions on RECURSION PHARMACEUTICALS, INC future price: according to them, RXRX price has a max estimate of 189.28 MXN and a min estimate of 75.71 MXN. Watch RXRX chart and read a more detailed RECURSION PHARMACEUTICALS, INC stock forecast: see what analysts think of RECURSION PHARMACEUTICALS, INC and suggest that you do with its stocks.
RXRX stock is 77.01% volatile and has beta coefficient of 3.58. Track RECURSION PHARMACEUTICALS, INC stock price on the chart and check out the list of the most volatile stocks — is RECURSION PHARMACEUTICALS, INC there?
Today RECURSION PHARMACEUTICALS, INC has the market capitalization of ‪39.66 B‬, it has decreased by −9.02% over the last week.
Yes, you can track RECURSION PHARMACEUTICALS, INC financials in yearly and quarterly reports right on TradingView.
RECURSION PHARMACEUTICALS, INC is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
RXRX earnings for the last quarter are −10.24 MXN per share, whereas the estimation was −10.57 MXN resulting in a 3.10% surprise. The estimated earnings for the next quarter are −6.68 MXN per share. See more details about RECURSION PHARMACEUTICALS, INC earnings.
RECURSION PHARMACEUTICALS, INC revenue for the last quarter amounts to ‪303.58 M‬ MXN, despite the estimated figure of ‪306.97 M‬ MXN. In the next quarter, revenue is expected to reach ‪309.94 M‬ MXN.
RXRX net income for the last quarter is ‪−4.15 B‬ MXN, while the quarter before that showed ‪−3.73 B‬ MXN of net income which accounts for −11.21% change. Track more RECURSION PHARMACEUTICALS, INC financial stats to get the full picture.
No, RXRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RECURSION PHARMACEUTICALS, INC EBITDA is ‪−10.77 B‬ MXN, and current EBITDA margin is −752.07%. See more stats in RECURSION PHARMACEUTICALS, INC financial statements.
Like other stocks, RXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RECURSION PHARMACEUTICALS, INC stock right from TradingView charts — choose your broker and connect to your account.